Article
Immune Compromising Conditions Impair SARS-CoV-2 Vaccine Humoral Immunogenicity Despite Multiple Booster Doses
2026-05-20
Abstract excerpt
<title>Abstract</title> <p>The healthcare burden of COVID-19 among immune compromised (IC) individuals remains high as variants continue to emerge and circulate. Data from 932 participants of the prospective cohort study “Stop the Spread Ottawa” was utilized to elucidate the influence of IC conditions on long-term COVID-19 vaccine humoral immunogenicity. IC conditions and immunosuppressant medications were catego...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1f8f60da-1519-58cb-92c8-61d725bbbd9d
- DOI
- 10.21203/rs.3.rs-9406334/v1
